Use of a calcium sulfate-based bone graft substitute for benign bone lesions.
Twenty-three patients with a benign bone lesion grafted with calcium sulfate, with and without demineralized bone matrix, were reviewed. At a minimum of 1 year postoperatively, 21 patients had achieved between 76% and 100% bone repair based on anteroposterior and lateral radiographs. Overall, the mean Enneking Functional Evaluation System score was 98%. Calcium sulfate is a well-tolerated, biodegradable, osteoconductive bone graft substitute. It is a reasonable alternative to autogenous bone graft for benign bone lesions.
Gitelis
S
S
Department of Orthopedic Surgery, Rush Medical College, Chicago, Ill 60612, USA.
Piasecki
P
P
Turner
T
T
Haggard
W
W
Charters
J
J
Urban
R
R
D020341:Absorbable Implants; D000293:Adolescent; D000328:Adult; D001845:Bone Cysts / Q000601:surgery; D001847:Bone Diseases / Q000000981:diagnostic imaging / Q000601:surgery*; D001857:Bone Matrix / Q000637:transplantation; D001861:Bone Regeneration / Q000187:drug effects; D018786:Bone Substitutes; D002133:Calcium Sulfate; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007512:Ischium / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D011859:Radiography; D012189:Retrospective Studies; D013977:Tibia / Q000000981:diagnostic imaging
D018786:Bone Substitutes; D002133:Calcium Sulfate